Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20160307026950N51Phase 2Completed
Phase 2, randomised, triple-blind trial comparing Intranasal ketamine + nitrous oxide with Oral midazolam + nitrous oxide (2 arms). Primary endpoints: Oxygen saturation, Pulse rate and 2 more. Started Jun 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20160307026950N51.